Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
University of Michigan Rogel Cancer Center
University of Michigan Rogel Cancer Center
Fred Hutchinson Cancer Center
Udayana University
Ezisurg Medical Co. Ltd.
University of Florida
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
National Taiwan University Hospital
Centre Francois Baclesse
Memorial Sloan Kettering Cancer Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Washington University School of Medicine
Sichuan Enray Pharmaceutical Sciences Company
Medical College of Wisconsin
Fudan University
University Medical Center Groningen
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Stanford University
Mayo Clinic
Seoul National University Hospital
Thomas Jefferson University
The First Affiliated Hospital of Zhengzhou University
Osaka University
University of Foggia
The First Affiliated Hospital of Xiamen University
Aristotle University Of Thessaloniki
University Hospital, Ghent
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
Centro de Excelencia en Enfermedades de Cabeza y Cuello
Alliance for Clinical Trials in Oncology
Rutgers, The State University of New Jersey
Chongqing General Hospital
The First Affiliated Hospital of Zhengzhou University
Regina Elena Cancer Institute
Chongqing General Hospital
Rigshospitalet, Denmark
Vanderbilt-Ingram Cancer Center
Yeditepe University
Royal Marsden NHS Foundation Trust
Chinese PLA General Hospital
Inha University Hospital
University Medical Center Groningen
University of Florida
Academic and Community Cancer Research United
Virginia Commonwealth University
Zhejiang Cancer Hospital
Fujian Medical University
Jiangxi Provincial Cancer Hospital